Back to Journals » Biologics: Targets and Therapy » Volume 7

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]

Authors Lurati AM, Bertani, Marrazza, Re, Bompane, scarpellini M

Received 19 June 2013

Accepted for publication 19 June 2013

Published 6 December 2013 Volume 2013:7 Pages 265—266

DOI https://doi.org/10.2147/BTT.S50190


 

Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M. Biologics: Targets and Therapy. 2012;6:83–87.
On page 87, the disclosure was listed as ‘The authors report no conflicts of interest in this work.’ in error. The correct disclosure should be ‘An unrestricted publication grant was provided by Roche S.p.A. The authors have no other conflicts of interest to report.’

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]